Skip to main content
SpringerLink
Log in

Hyperbilirubinämie und Morbus haemolyticus neonatorum

  • Chapter
  • First Online:
Obladens Neugeborenenintensivmedizin

  • 458 Accesses

Zusammenfassung

Die Hyperbilirubinämie des Neugeborenen ist nach wie vor aktuell, zumal in den letzten Jahren auch in Ländern mit entwickeltem Gesundheitswesen der Kernikterus erneut aufgetreten ist. Kritische Grenzen der Bilirubinkonzentration bei Früh- und Reifgeborenen werden ebenso dargestellt wie das differenzialdiagnostische Vorgehen bei Hyperbilirubinämie. Besonderes Augenmerk wird auf den Morbus haemolyticus neonatorum gelegt. Die praktische Durchführung von Fototherapie und Blutaustauschtransfusion wird detailliert beschrieben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Alshehri AA, Jackson DE (2021) Non-invasive prenatal fetal blood group genotype and its application in the management of hemolytic disease of fetus and newborn: systematic review and meta-analysis. Transfus Med Rev 35(2):85–94

    Article  PubMed  Google Scholar 

  2. American Academy of Pediatrics. Subcommittee on Hyperbilirubinemia (2004) Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114(1):297–316

    Google Scholar 

  3. Bhutani VK, Johnson L (2006) Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol 30(2):89–97

    Article  PubMed  Google Scholar 

  4. Bhutani VK, Johnson L, Sivieri EM (1999) Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103(1):6–14

    Article  CAS  PubMed  Google Scholar 

  5. Bijl EJ, Bharwani KD, Houwen RH, de Man RA (2013) The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review. Neth J Med 71(4):170–173

    CAS  PubMed  Google Scholar 

  6. Donneborg ML, Hansen BM, Vandborg PK, Rodrigo-Domingo M, Ebbesen F (2020) Extreme neonatal hyperbilirubinemia and kernicterus spectrum disorder in Denmark during the years 2000–2015. J Perinatol 40(2):194–202

    Article  PubMed  Google Scholar 

  7. Ghesquière L, Garabedian C, Coulon C, Verpillat P, Rakza T, Wibaut B, et al. (2018) Management of red blood cell alloimmunization in pregnancy. J Gynecol Obstet Hum Reprod 47(5):197–204

    Google Scholar 

  8. GNPI (2015) Hyperbilirubinämie des Neugeborenen – Diagnostik und Therapie. AWMF-Leitlinie 024-007

    Google Scholar 

  9. Gotink MJ, Benders MJ, Lavrijsen SW, Rodrigues Pereira R, Hulzebos CV, Dijk PH (2013) Severe neonatal hyperbilirubinemia in the Netherlands. Neonatology 104(2):137–142

    Article  PubMed  Google Scholar 

  10. Hulzebos CV, Dijk PH, van Imhoff DE, Bos AF, Lopriore E, Offringa M, et al. (2014) The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial – BARTrial. PLoS One 9(6):e99466

    Google Scholar 

  11. Hulzebos CV, Vader-van Imhoff DE, Bos AF, Dijk PH (2019) Should transcutaneous bilirubin be measured in preterm infants receiving phototherapy? The relationship between transcutaneous and total serum bilirubin in preterm infants with and without phototherapy. PLoS One 14(6):e0218131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hynes S, Moore Z, Patton D, O’Connor T, Nugent L (2020) Accuracy of transcutaneous bilirubin versus serum bilirubin measurement in preterm infants receiving phototherapy: a systematic review. Adv Neonatal Care 20(6):E118–e126

    Article  PubMed  Google Scholar 

  13. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM (2009) Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 29(Suppl 1):S25–S45

    Article  PubMed  Google Scholar 

  14. Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, et al. (2022) Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics 150:e2022058859.

    Google Scholar 

  15. Kumar P, Chawla D, Deorari A (2011) Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database Syst Rev 2011(12):CD007969

    PubMed  PubMed Central  Google Scholar 

  16. Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S, Newman TB (2014) Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics 134(3):504–509

    Article  PubMed  Google Scholar 

  17. Lieberman L, Lopriore E, Baker JM, Bercovitz RS, Christensen RD, Crighton G, et al. (2022) International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn. Br J Haematol 198(1):183–195

    Google Scholar 

  18. Maisels MJ, Watchko JF (2003) Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 88(6):F459–F463

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK (2012) An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol 32(9):660–664

    Article  CAS  PubMed  Google Scholar 

  20. Manning D, Todd P, Maxwell M, Jane Platt M (2007) Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 92(5):F342–F346

    Article  PubMed  PubMed Central  Google Scholar 

  21. Mills JF, Tudehope D (2001) Fibreoptic phototherapy for neonatal jaundice. Cochrane Database Syst Rev 2001(1):CD002060

    PubMed  PubMed Central  Google Scholar 

  22. Newman TB, Maisels MJ (2000) Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines. Pediatrics 105(1 Pt 3):242–245

    Article  CAS  PubMed  Google Scholar 

  23. Okwundu CI, Okoromah CA, Shah PS (2012) Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. Cochrane Database Syst Rev 1:CD007966

    PubMed  Google Scholar 

  24. Sgro M, Kandasamy S, Shah V, Ofner M, Campbell D (2016) Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian guidelines. J Pediatr 171:43–47

    Article  PubMed  Google Scholar 

  25. Tyraskis A, Parsons C, Davenport M (2018) Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy. Cochrane Database Syst Rev 5(5):CD008735

    PubMed  Google Scholar 

  26. van Imhoff DE, Dijk PH, Hulzebos CV (2011) Uniform treatment thresholds for hyperbilirubinemia in preterm infants: background and synopsis of a national guideline. Early Hum Dev 87(8):521–525

    Article  PubMed  Google Scholar 

  27. Wildhaber B, McLin V (2010) Schweizerisches Screeningprogramm für Gallengangatresie. Swiss Med Forum 10(28):480–482

    Article  Google Scholar 

  28. Wu YW, Kuzniewicz MW, Wickremasinghe AC, Walsh EM, Wi S, McCulloch CE, Newman TB (2015) Risk for cerebral palsy in infants with total serum bilirubin levels at or above the exchange transfusion threshold: a population-based study. JAMA Pediatr 169(3):239–246

    Article  PubMed  Google Scholar 

  29. Zwiers C, Scheffer-Rath ME, Lopriore E, de Haas M, Liley HG (2018) Immunoglobulin for alloimmune hemolytic disease in neonates. Cochrane Database Syst Rev 3(3):CD003313

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum für Kinder- und Jugendmedizin, Philipps-Universität Marburg, Marburg, Deutschland

    Rolf F. Maier

Authors
  1. Rolf F. Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rolf F. Maier .

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Maier, R.F. (2023). Hyperbilirubinämie und Morbus haemolyticus neonatorum. In: Obladens Neugeborenenintensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-66572-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-66572-5_13

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-66571-8

  • Online ISBN: 978-3-662-66572-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation